ImportRefusal LogoImportRefusal

Beauty International Sylwia Michno

⚠️ Moderate Risk

FEI: 3011105145 • Rudawa, Malopolskie • POLAND

FEI

FEI Number

3011105145

📍

Location

Rudawa, Malopolskie

🇵🇱

Country

POLAND
🏢

Address

Mlynka 58, , Rudawa, Malopolskie, Poland

Moderate Risk

FDA Import Risk Assessment

46.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

22
Total Refusals
5
Unique Violations
3/16/2021
Latest Refusal
4/22/2016
Earliest Refusal

Score Breakdown

Violation Severity
66.7×40%
Refusal Volume
50.4×30%
Recency
3.1×20%
Frequency
44.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7520×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

11813×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

328013×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4712×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

1971×

COSM COLOR

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain a color additive which is unsafe within the meaning of Section 721(a) which renders it adulterated under Section 601(e).

Refusal History

DateProductViolationsDivision
3/16/2021
53LD99OTHER SKIN CARE PREPARATIONS, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
7/5/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Cincinnati District Office (CIN-DO)
4/22/2016
53LC06MOISTURIZING (SKIN CARE PREPARATIONS)
471CSTIC LBLG
Cincinnati District Office (CIN-DO)
4/22/2016
53LC06MOISTURIZING (SKIN CARE PREPARATIONS)
197COSM COLOR
471CSTIC LBLG
Cincinnati District Office (CIN-DO)
4/22/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
4/22/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
4/22/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
4/22/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
4/22/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
4/22/2016
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Beauty International Sylwia Michno's FDA import refusal history?

Beauty International Sylwia Michno (FEI: 3011105145) has 22 FDA import refusal record(s) in our database, spanning from 4/22/2016 to 3/16/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Beauty International Sylwia Michno's FEI number is 3011105145.

What types of violations has Beauty International Sylwia Michno received?

Beauty International Sylwia Michno has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Beauty International Sylwia Michno come from?

All FDA import refusal data for Beauty International Sylwia Michno is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.